Who are SER120 750 ng's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): RX0041 4%, LID104.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ser120-750-ng.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

SER120 750 ng — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SER120 750 ng (SER120 750 ng) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Serotonin receptor modulator. Area: Psychiatry.

phase 3 Serotonin receptor modulator 5-HT receptor Psychiatry Small molecule Live · refreshed every 30 min

Target snapshot

SER120 750 ng (SER120 750 ng) — Serenity Pharmaceuticals, Inc.. SER120 is a small molecule that targets the serotonin receptor.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
SER120 750 ng TARGET	SER120 750 ng	Serenity Pharmaceuticals, Inc.	phase 3	Serotonin receptor modulator	5-HT receptor
RX0041 4%	RX0041 4%	Pharmaceutical Project Solutions, Inc.	phase 3	SSRI	5-HT receptor
LID104	LID104	EMS	phase 3	SSRI	5-HT receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Serotonin receptor modulator class)

AL-S Pharma · 1 drug in this class
Serenity Pharmaceuticals, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SER120 750 ng — Competitive Intelligence Brief. https://druglandscape.com/ci/ser120-750-ng. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab